D
BridgeBio Oncology Therapeutics, Inc. BBOT
$9.71 $0.879.84% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Corporate Info
Website
Phone Number
650 405 4770
Address
256 E. Grand Avenue
Suite 104
South San Francisco, CA 94080
Country
United States
Year Founded
--
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
62
Business Decription
BridgeBio Oncology Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of small molecule inhibitor for cancer patients. The company is based in South San Francisco, California. BridgeBio Oncology Therapeutics, Inc. operates as a subsidiary of BridgeBio Pharma, Inc.